Company Filing History:
Years Active: 1981-1984
Title: Barbara E Loughman: Innovator in Immunosuppressive Agents
Introduction
Barbara E Loughman is a prominent inventor based in Richland, MI (US). She has made significant contributions to the field of immunology, particularly in the development of novel compounds for treating autoimmune diseases and organ transplant rejection. With a total of 3 patents, her work has garnered attention for its potential impact on medical treatments.
Latest Patents
Loughman's latest patents include innovative compounds such as carbamic acid derivatives, which serve as selective immunosuppressive agents. These novel cyclized .omega.-carboxyethyl mono or dithiocarbanilic acids are disclosed as immunoregulatory agents, useful in the treatment of organ transplant rejection phenomena and autoimmune diseases, particularly where a delayed hypersensitivity component has been established, such as multiple sclerosis. Additionally, she has developed 1,3-thiazin-4-one compounds that further enhance the therapeutic options available for these conditions.
Career Highlights
Barbara E Loughman has had a distinguished career, working at The Upjohn Company, where she has been able to apply her expertise in immunology to develop groundbreaking treatments. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Loughman has collaborated with notable professionals, including her coworker David John Anderson, to advance her research and patent applications. These collaborations have played a crucial role in the development of her innovative compounds.
Conclusion
Barbara E Loughman's contributions to immunology through her patents and research have the potential to significantly improve treatment options for patients with autoimmune diseases and those undergoing organ transplants. Her work exemplifies the impact of innovation in the medical field.